Seqirus USA INC.:1334893 [23-005280] influenza vaccine from the US manufacturer seqirus USA, INC
Ended Awarded Last action
- Contract number
- 75N90023F00001
- Awardee
-
Seqirus USA Inc. UEI N6U7P2B9VHS5
- Awarding agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Obligated
- $296,361
Award facts
- Contract value 100% obligated
- $296,361.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Summit, NJ 07901, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $1,700 | |
| Funding Only Action | -$13,005 | |
| Original award | $307,666 |
About this award
Seqirus USA Inc. was awarded a $296,361 firm fixed price contract by the Department of Health and Human Services' National Institutes of Health Clinical Center to deliver influenza vaccine from the U.S. manufacturer's facilities in Summit, New Jersey. The contract calls for Seqirus USA Inc. to provide influenza vaccine under the General Services Administration Pharmaceuticals and Drugs schedule, referred to as FSS-61-IB, with performance running through April 2025. No set-aside provision was specified. As the sole awardee, Seqirus USA Inc. will fulfill the NIH Clinical Center's vaccine requirements without use of major subcontractors. The contract supports the agency's patient care and research efforts through reliable domestic sourcing of influenza vaccine.
Quick answers
Who was awarded contract 75N90023F00001?
75N90023F00001 was awarded to Seqirus USA Inc. by NIH Clinical Center (National Institutes of Health) on April 27, 2020.
How much is contract 75N90023F00001 worth?
The government has obligated $296,361 on 75N90023F00001.
Is contract 75N90023F00001 an order under another contract?
Yes. 75N90023F00001 is a BPA call under V797D70074-75N90020A00004, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75N90023F00001 competed?
The extent of competition for 75N90023F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award